EyeConic: Qualification for Cone-Optogenetics

Recruiting now

Conditions studied: Retinal Dystrophies

In brief

This study aims to prepare for the first-in-human clinical trial of cone optogenetics vision restoration. As a first step, this worldwide multicenter ocular imaging study (EyeConic Study) is performed to identify eligible patients.

Key facts

Study ID

NCT05294978

Run by

Institute of Molecular and Clinical Ophthalmology Basel

People needed

1000

Starts

2021-07-01

Expected to finish

2026-12-01

Last updated by the study team

2025-07-31

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

Where it is running

• University of California San Francisco, Department of Ophthalmology — San Francisco, California, United States (enrolling)
• Bascom Palmer Eye Institute — Miami, Florida, United States (enrolling)
• University of Pittsburgh, Department of Ophthalmology — Pittsburgh, Pennsylvania, United States (enrolling)
• Beijing Institute of Ophthalmology — Beijing, China (enrolling)
• Universitätsklinikum Tübingen Augenklinik — Tübingen, Germany (enrolling)
• Semmelweis University, Department of Ophthalmology — Budapest, Hungary (enrolling)
• Oculista Ospedale Parma — Parma, Italy (enrolling)
• University Hospital Basel, Eye Clinic — Basel, Switzerland (enrolling)
• Moorfields Eye Hospital — London, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.